5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in the treatment of lymphoma.

Suppr

超能文献

作者信息

Frei E, Luce J K, Talley R W, Vaitkevicius V K, Wilson H E

出版信息

Cancer Chemother Rep. 1972 Oct;56(5):667-70.

PMID:4569060

Abstract

摘要

相似文献

5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in the treatment of lymphoma.

Cancer Chemother Rep. 1972 Oct;56(5):667-70.

Clinical experience with 5-(3,3-bis(2-chloroethyl)-1-triazeno)imidazole-4-carboxamide (NSC-82196) in the treatment of metastatic malignant melanoma.5-（3,3-双（2-氯乙基）-1-三氮烯基）咪唑-4-甲酰胺（NSC-82196）治疗转移性恶性黑色素瘤的临床经验

Cancer Chemother Rep. 1972 Oct;56(5):671-7.

5-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in the treatment of advanced acute lymphocytic leukemia in children.

Cancer Chemother Rep. 1972 Aug;56(4):523-6.

Study of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in patients with disseminated melanoma.5-（3,3-二甲基-1-三氮烯基）咪唑-4-甲酰胺（NSC-45388）治疗播散性黑色素瘤患者的研究。

Cancer Chemother Rep. 1973 Feb;57(1):83-4.

Clinical trials with the antitumor agent 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide(NSC-45388).使用抗肿瘤药物5-（3,3-二甲基-1-三氮烯基）咪唑-4-甲酰胺（NSC-45388）的临床试验。

Cancer Chemother Rep. 1970 Apr;54(2):119-24.

Chemotherapy of sarcomas with a combination of adriamycin and dimethyl triazeno imidazole carboxamide.阿霉素与二甲基三氮烯咪唑甲酰胺联合用于肉瘤的化疗。

Cancer. 1972 Dec;30(6):1632-8. doi: 10.1002/1097-0142(197212)30:6<1632::aid-cncr2820300632>3.0.co;2-s.

Intra-arterial infusion therapy with 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (NSC 45388) for malignant melanoma.采用5-（3,3-二甲基-1-三氮烯基）咪唑-4-甲酰胺（NSC 45388）进行动脉内灌注治疗恶性黑色素瘤。

Cancer. 1973 Oct;32(4):749-55. doi: 10.1002/1097-0142(197310)32:4<749::aid-cncr2820320403>3.0.co;2-1.

Effective treatment of Kaposi's sarcoma with 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388).用5-（3,3-二甲基-1-三氮烯基）咪唑-4-甲酰胺（NSC-45388）有效治疗卡波西肉瘤。

Cancer Chemother Rep. 1973 Feb;57(1):65-71.

5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in patients with gastrointestinal carcinoma.5-（3,3-二甲基-1-三氮烯基）咪唑-4-甲酰胺（NSC-45388）用于胃肠道癌患者。

Cancer Chemother Rep. 1970 Dec;54(6):471-3.

Fluorouracil, imidazole carboxamide dimethyl triazeno, vincristine, and bis-chloroethyl nitrosourea in colon cancer.氟尿嘧啶、咪唑甲酰胺二甲基三氮烯、长春新碱和双氯乙基亚硝脲用于结肠癌治疗

Cancer. 1974 May;33(5):1207-9. doi: 10.1002/1097-0142(197405)33:5<1207::aid-cncr2820330502>3.0.co;2-9.

引用本文的文献

Doxorubicin, vinblastine, and gemcitabine (CALGB 50203) for stage I/II nonbulky Hodgkin lymphoma: pretreatment prognostic factors and interim PET.多柔比星、长春碱和吉西他滨（CALGB 50203）治疗 I/II 期非肿块性霍奇金淋巴瘤：预处理预后因素和中期 PET。

Blood. 2011 May 19;117(20):5314-20. doi: 10.1182/blood-2010-10-314260. Epub 2011 Feb 25.

A phase I clinical and pharmacological profile of dacarbazine with autologous bone marrow transplantation in patients with solid tumors.达卡巴嗪联合自体骨髓移植治疗实体瘤患者的I期临床及药理学研究

Invest New Drugs. 1993 May-Aug;11(2-3):169-79. doi: 10.1007/BF00874151.

[Results of treatment with ABVD in C-MOPP-resistant Hodgkin's disease (author's transl)].ABVD 治疗对 C-MOPP 耐药的霍奇金病的结果（作者译）

Klin Wochenschr. 1981 Mar 16;59(6):267-73. doi: 10.1007/BF01478205.

Combination chemotherapy for the treatment of Hodgkin's disease in relapse. Results with lomustine (CCNU), melphalan (Alkeran), and vindesine (DVA) alone (CAD) and in alternation with MOPP and doxorubicin (Adriamycin), bleomycin, and vinblastine (ABV).联合化疗治疗复发性霍奇金病。洛莫司汀（环己亚硝脲）、美法仑（左旋苯丙氨酸氮芥）和长春地辛单独使用（CAD方案）以及与MOPP方案交替使用并联合阿霉素、博来霉素和长春花碱（ABV方案）的疗效。

Cancer Chemother Pharmacol. 1983;11(2):80-5. doi: 10.1007/BF00254250.

[Carcinogenic activity of 13 aryldialkyl triazenes in BD-rats (author's transl)].13种芳基二烷基三氮烯对BD大鼠的致癌活性（作者译）

Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 1974;81(3-4):285-310. doi: 10.1007/BF00305031.

N-methyl antitumour agents. A distinct class of anticancer drugs?N-甲基抗肿瘤药物。一类独特的抗癌药物？

Cancer Chemother Pharmacol. 1987;19(2):91-102. doi: 10.1007/BF00254559.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验